Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.
source https://www.sciencedaily.com/releases/2024/06/240619182323.htm
I've studied organizational failure for decades—the Church of England needs
more than a new leader
-
In a book I wrote with a colleague on organizational failures (The Apology
Impulse) the inability of many of them to confront their failures, except
to say...
15 hours ago
No comments:
Post a Comment